Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor

Brain Research

Volumn 859, Issue 1, 2000, Pages 45-56

  Sullivan, Michael E ^a   Hall, Sean R ^a   Milne, Brian ^a   Jhamandas, Khem ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Locus coeruleus; Microdialysis; Morphine withdrawal; Soluble guanlylyl cyclase inhibitor; Voltammetry

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; GUANYLATE CYCLASE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; NITRIC OXIDE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; LOCUS CERULEUS; MALE; MICRODIALYSIS; NERVE CONDUCTION; NONHUMAN; NORADRENERGIC NERVE; POTENTIOMETRY; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CYCLIC GMP; ENZYME INHIBITORS; EXCITATORY AMINO ACIDS; GUANYLATE CYCLASE; LOCUS COERULEUS; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OXADIAZOLES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0034678014     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02481-6     Document Type: Article

References (63)

1. M.L. Adams, J.M. Kalicki, E.R. Meyer, T.J. Cicero, Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester, Life Sci. 52 (1993) L245-L249.
2. G.K. Aghajanian, Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine, Nature 276 (1978) 186-188.
3. G.K. Aghajanian, J.H. Kogan, B. Moghaddam, Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study, Brain Res. 636 (1994) 126-130.
4. M. Alreja, G.K. Aghajanian, Pacemaker activity of locus coeruleus neurons: whole-cell recordings in brain slices show dependence on cAMP and protein kinase A, Brain Res. 556 (1991) 339-343.
5. W.P. Arnold, C.K. Mittal, S. Katsuki, F. Murad, Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations, Proc. Natl. Acad. Sci. U. S. A. 74 (1977) 3203-3207.
6. G. Aston-Jones, H. Hirata, H. Akaoka, Local opiate withdrawal in locus coeruleus in vivo, Brain Res. 765 (1997) 331-336.
7. G. Aston-Jones, M.T. Shipley, G. Chouvet, M. Ennis, E. van Bockstaele, V. Pieribone, R. Shiekhattar, H. Akaoka, G. Drolet, B. Astier, Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology, Prog. Brain Res. 88 (1991) 47-75, [Review] [140 Refs.].
8. H.N. Bhargava, S.N. Thorat, Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome, Pharmacology 52 (1996) 86-91.
9. J. Blasig, A. Herz, K. Reinhold, S. Zieglgansberger, Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats, Psychopharmacologia 33 (1973) 19-38.
10. M.B. Bogdanov, R.J. Wurtman, Possible involvement of nitric oxide in NMDA-induced glutamate release in the rat striatum: an in vivo microdialysis study, Neurosci. Lett. 221 (1997) 197-201.
11. C.L. Boulton, E. Southam, J. Garthwaite, Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase, Neuroscience 69 (1995) 699-703.
12. D.S. Bredt, S.H. Snyder, Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum, Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 9030-9033.
13. M. Buda, G. De Simoni, F. Gonon, J.F. Pujol, Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry: I. Nature and origin of contributors to the oxidation current at +0.1 V, Brain Res. 273 (1983) 197-206.
14. S.L. Cappendijk, S.Y. Duval, R. de Vries, M.R. Dzoljic, Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats, Neurosci. Lett. 183 (1995) 67-70.
15. M.J. Christie, J.T. Williams, P.B. Osborne, C.E. Bellchambers, Where is the locus in opioid withdrawal?, Trends Pharmacol. Sci. 18 (1997) 134-140, [Review] [73 Refs.].
16. O. Curet, T. Dennis, B. Scatton, The formation of deaminated metabolites of dopamine in the locus coeruleus depends upon noradrenergic neuronal activity, Brain Res. 335 (1985) 297-301.
17. F.E. D'Amour, D.L. Smith, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72 (1941) 74-79.
18. C. Desvignes, F. Robert, C. Vachette, G. Chouvet, R. Cespuglio, B. Renaud, L. Lambas-Senas, Monitoring nitric oxide (NO) in rat locus coeruleus: differential effects of NO synthase inhibitors, NeuroReport 8 (1997) 1321-1325.
19. R.S. Duman, J.F. Tallman, E.J. Nestler, Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus, J. Pharmacol. Exp. Ther. 246 (1988) 1033-1039.
20. E. Fedele, Y. Jin, G. Varnier, M. Raiteri, In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway, Br. J. Pharmacol. 119 (1996) 590-594.
21. J. Garthwaite, S.L. Charles, R. Chess-Williams, Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature 336 (1988) 385-388.
22. J. Garthwaite, E. Southam, C.L. Boulton, E.B. Nielsen, K. Schmidt, B. Mayer, Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, Mol. Pharmacol. 48 (1995) 184-188.
23. F. Gonon, M. Buda, G. De Simoni, J.F. Pujol, Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry: II. Pharmacological and behavioral study, Brain Res. 273 (1983) 207-216.
24. F. Gonon, M. Buda, J.F. Pujol, Treated carbon fibre electrodes for measuring catechols and ascorbic acid, in: C.A. Marsden (Ed.), Measurement of Neurotransmitter Release In Vivo, New York, 1984, pp. 153-171.
25. S. Hall, B. Milne, K. Jhamandas, Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study, Brain Res. 739 (1996) 182-191.
26. M. Hong, B. Milne, K. Jhamandas, Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus, Brain Res. 623 (1993) 131-141.
27. M. Hong, B. Milne, C.W. Loomis, K. Jhamandas, In vivo catechol activity in the rat locus coeruleus following different nociceptive stimuli and naloxone, Can. J. Physiol. Pharmacol. 70 (1992) 1082-1089.
28. T. Kano, M. Shimizu-Sasamata, P.L. Huang, M.A. Moskowitz, E.H. Lo, Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo, Neuroscience 86 (1998) 695-699.
29. A.S. Kimes, D.B. Vaupel, E.D. London, Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase, Psychopharmacology 112 (1993) 521-524.
30. J.H. Kogan, E.J. Nestler, G.K. Aghajanian, Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats, Eur. J. Pharmacol. 211 (1992) 47-53.
31. E. Laschka, H. Teschemacher, P. Mehraein, A. Herz, Sites of action of morphine involved in the development of physical dependence in rats: II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas, Psychopharmacologia 46 (1976) 141-147.
32. C.W. Loomis, B. Milne, F.W. Cervenko, Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps, Pharmacol. Biochem. Behav. 26 (1987) 131-139.
33. P.H. Luppi, G. Aston-Jones, H. Akaoka, G. Chouvet, M. Jouvet, Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin, Neuroscience 65 (1995) 119-160.
34. J.M. Luque, P. Malherbe, J.G. Richards, Localization of NMDA receptor subunit mRNAs in the rat locus coeruleus, Brain Res., Molecular (1994) 224-232.
35. N.H. Majeed, B. Przewlocka, H. Machelska, R. Przewlocki, Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice, Neuropharmacology 33 (1994) 189-192.
36. R. Maldonado, G.F. Koob, Destruction of the locus coeruleus decreases physical signs of opiate withdrawal, Brain Res. 605 (1993) 128-138.
37. R. Maldonado, L. Stinus, L.H. Gold, G.F. Koob, Role of different brain structures in the expression of the physical morphine withdrawal syndrome, J. Pharmacol. Exp. Ther. 261 (1992) 669-677.
38. G. Maura, M. Raiteri, Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro, J. Neurochem. 66 (1996) 203-209.
39. B. Milne, L. Quintin, J.Y. Gillon, J.F. Pujol, Fentanyl decreases catecholamine metabolism measured by in vivo voltammetry in the rat locus coeruleus, Can. J. Physiol. Pharmacol. 67 (1989) 532-536.
40. F. Murad, C.K. Mittal, W.P. Arnold, S. Katsuki, H. Kimura, Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin, Adv. Cyclic Nucleotide Res. 9 (1978) 145-158, [Review] [55 Refs.].
41. E.J. Nestler, J.J. Erdos, R. Terwilliger, R.S. Duman, J.F. Tallman, Regulation of G proteins by chronic morphine in the rat locus coeruleus, Brain Res. 476 (1989) 230-239.
42. E.J. Nestler, J.F. Tallman, Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus, Mol. Pharmacol. 33 (1988) 127-132.
43. S. Oh, P.P. McCaslin, Kainate produces concentration-dependent elevation of glutamate release but not cGMP levels in cultured neuron, Gen. Pharmacol. 27 (1996) 83-87.
44. C. Ortemann, F. Robert, B. Renaud, L. Lambas-Senas, In vivo microdialysis study of the extracellular 3,4-dihydroxyphenylacetic acid in the rat locus ceruleus: topographical and pharmacological aspects, J. Neurochem. 61 (1993) 594-601.
45. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
46. J. Pineda, J.H. Kogan, G.K. Aghajanian, Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel, J. Neurosci. 16 (1996) 1389-1399.
47. J. Pineda, M. Torrecilla, R. Martin-Ruiz, L. Ugedo, Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine dependent rats, Neuropharmacology 37 (1998) 759-767.
48. L.J. Punch, D.W. Self, E.J. Nestler, J.R. Taylor, Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray, J. Neurosci. 17 (1997) 8520-8527.
49. L. Quintin, G. Hilaire, P.F. Pujol, Variations in DOPAC concentration are correlated to single cell firing changes in the rat locus coeruleus, J. Neurosci. 18 (1986) 889-899.
50. K. Rasmussen, G.K. Aghajanian, Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis, Brain Res. 505 (1989) 346-350.
51. K. Rasmussen, D.B. Beitner-Johnson, J.H. Krystal, G.K. Aghajanian, E.J. Nestler, Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates, J. Neurosci. 10 (1990) 2308-2317.
52. K. Rasmussen, J.H. Krystal, G.K. Aghajanian, Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration, Psychopharmacology 105 (1991) 508-512.
53. J. Rodrigo, D.R. Springall, O. Uttenthal, M.L. Bentura, F. Abadia-Molina, V. Riveros-Moreno, R. Martinez-Murillo, J.M. Polak, S. Moncada, Localization of nitric oxide synthase in the adult rat brain, Philos. Trans. R. Soc. London, Ser. B: Biol. Sci. 345 (1994) 175-221.
54. M. Salter, P.J. Strijbos, S. Neale, C. Duffy, R.L. Follenfant, J. Garthwaite, The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway, Neuroscience 73 (1996) 649-655.
55. W.K. Sonnenburg, J.A. Beavo, Cyclic GMP and regulation of cyclic nucleotide hydrolysis, Adv. Pharmacol. 26 (1994) 87-114, [Review] [116 Refs.].
56. M.F. Suaud-Chagny, R. Cespuglio, J.P. Rivot, M. Buda, F. Gono, High sensitivity of brain catechols and indoles in vivo using electrochemically treated carbon fiber electrodes, J. Neurosci. Methods 48 (1993) 241-250.
57. A. Tempel, R.S. Zukin, Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography, Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 4308-4312.
58. K.A. Trujillo, H. Akil, Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists, Brain Res. 633 (1994) 178-188.
59. R.J. Valentino, R.G. Wehby, Locus ceruleus discharge characteristics of morphine-dependent rats: effects of naltrexone, Brain Res. 488 (1989) 126-134.
60. E.J. Van Bockstaele, E.E. Colago, Selective distribution of the NMDA-R1 glutamate receptor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat brain: an immunoelectron microscopic study, J. Comp. Neurol. 369 (1996) 483-496.
61. Z.Q. Xu, J. de Vente, H. Steinbusch, S. Grillner, T. Hokfelt, The NO-cGMP pathway in the rat locus coeruleus: electrophysiological, immunohistochemical and in situ hybridization studies, Eur. J. Neurosci. 10 (1998) 3508-3516.
62. Z.Q. Xu, V.A. Pieribone, X. Zhang, S. Grillner, T. Hokfelt, A functional role for nitric oxide in locus coeruleus: immunohistochemical and electrophysiological studies, Exp. Brain Res. 98 (1994) 75-83.
63. T. Zhang, Y. Feng, R.W. Rockhold, I.K. Ho, Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat, Life Sci. 55 (1994) L25-L31.